Table 3.
HR | CI | P-value | |
Male sex | 0.681 | 0.156-2.971 | 0.609 |
Age | 1.004 | 0.932-1.081 | 0.922 |
Aetiology of HCC | |||
Alcoholic liver disease | 0.775 | 0.155-3.887 | 0.757 |
Hepatitis C | 3.272 | 0.798-13.417 | 0.100 |
Haemochromatosis | 1.210 | 0.243-6.024 | 0.816 |
Other | 0.027 | 0.000-16.500 | 0.271 |
Pre-operative α-fetoprotein > 100 ng/mL | 6.668 | 1.661-26.768 | 0.007 |
Compliant with Milan criteria | 1.354 | 0.271-6.761 | 0.712 |
Compliant with UCSF criteria | 0.739 | 0.148-3.692 | 0.712 |
Largest lesion | 1.326 | 0.976-1.801 | 0.071 |
Cirrhosis | 23.025 | 0.000-327.873 | 0.604 |
Steatosis | 0.045 | 0.000-546.731 | 0.664 |
Multifocal lesions | 2.100 | 0.494-8.930 | 0.315 |
Micro-vascular invasion | 1.560 | 0.376-6.463 | 0.540 |
Tumour differentiation | |||
Well | 0.249 | 0.046-1.340 | 0.105 |
Moderate | 1.553 | 0.374-6.443 | 0.544 |
Poor | 5.631 | 1.074-29.510 | 0.041 |
Incidental lesions | 0.041 | 0.000-720.752 | 0.523 |
HCC: Hepatocellular carcinoma; UCSF: University of California San Francisco.